GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Honliv Healthcare Management Group Co Ltd (HKSE:09906) » Definitions » ROE %

Honliv Healthcare Management Group Co (HKSE:09906) ROE % : 7.21% (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Honliv Healthcare Management Group Co ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Honliv Healthcare Management Group Co's annualized net income for the quarter that ended in Jun. 2024 was HK$43.2 Mil. Honliv Healthcare Management Group Co's average Total Stockholders Equity over the quarter that ended in Jun. 2024 was HK$598.8 Mil. Therefore, Honliv Healthcare Management Group Co's annualized ROE % for the quarter that ended in Jun. 2024 was 7.21%.

The historical rank and industry rank for Honliv Healthcare Management Group Co's ROE % or its related term are showing as below:

HKSE:09906' s ROE % Range Over the Past 10 Years
Min: 5.84   Med: 8.4   Max: 52.56
Current: 6.13

During the past 7 years, Honliv Healthcare Management Group Co's highest ROE % was 52.56%. The lowest was 5.84%. And the median was 8.40%.

HKSE:09906's ROE % is ranked better than
52.8% of 625 companies
in the Healthcare Providers & Services industry
Industry Median: 4.7 vs HKSE:09906: 6.13

Honliv Healthcare Management Group Co ROE % Historical Data

The historical data trend for Honliv Healthcare Management Group Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Honliv Healthcare Management Group Co ROE % Chart

Honliv Healthcare Management Group Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial 28.71 5.84 6.84 8.40 6.95

Honliv Healthcare Management Group Co Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.90 5.72 8.67 5.11 7.21

Competitive Comparison of Honliv Healthcare Management Group Co's ROE %

For the Medical Care Facilities subindustry, Honliv Healthcare Management Group Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Honliv Healthcare Management Group Co's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Honliv Healthcare Management Group Co's ROE % distribution charts can be found below:

* The bar in red indicates where Honliv Healthcare Management Group Co's ROE % falls into.



Honliv Healthcare Management Group Co ROE % Calculation

Honliv Healthcare Management Group Co's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=41.903/( (613.597+592.668)/ 2 )
=41.903/603.1325
=6.95 %

Honliv Healthcare Management Group Co's annualized ROE % for the quarter that ended in Jun. 2024 is calculated as

ROE %=Net Income (Q: Jun. 2024 )/( (Total Stockholders Equity (Q: Dec. 2023 )+Total Stockholders Equity (Q: Jun. 2024 ))/ count )
=43.152/( (592.668+604.905)/ 2 )
=43.152/598.7865
=7.21 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Jun. 2024) net income data. ROE % is displayed in the 30-year financial page.


Honliv Healthcare Management Group Co  (HKSE:09906) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Jun. 2024 )
=Net Income/Total Stockholders Equity
=43.152/598.7865
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(43.152 / 893.914)*(893.914 / 1064.105)*(1064.105 / 598.7865)
=Net Margin %*Asset Turnover*Equity Multiplier
=4.83 %*0.8401*1.7771
=ROA %*Equity Multiplier
=4.06 %*1.7771
=7.21 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Jun. 2024 )
=Net Income/Total Stockholders Equity
=43.152/598.7865
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (43.152 / 60.474) * (60.474 / 71.992) * (71.992 / 893.914) * (893.914 / 1064.105) * (1064.105 / 598.7865)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7136 * 0.84 * 8.05 % * 0.8401 * 1.7771
=7.21 %

Note: The net income data used here is two times the semi-annual (Jun. 2024) net income data. The Revenue data used here is two times the semi-annual (Jun. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Honliv Healthcare Management Group Co ROE % Related Terms

Thank you for viewing the detailed overview of Honliv Healthcare Management Group Co's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Honliv Healthcare Management Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Bo Ai Road (South), Changyuan County, Henan Province, Xinxiang, CHN
Honliv Healthcare Management Group Co Ltd is engaged in providing comprehensive medical services and pharmaceutical services to the society in Mainland China. The company generates revenue from Treatment and general Healthcare services, and Pharmaceutical sales.
Executives
Tct (bvi) Limited 2501 Other
The Core Trust Company Limited 2301 Trustee
Hwabao Trust Co., Ltd 2301 Trustee
Zhang Yuan Shi Tou Zi Ji Tuan You Xian Gong Si 2101 Beneficial owner
Rubrical Investment Limited 2501 Other
Sunny Rock Capital Limited 2101 Beneficial owner
Cao Jinming 2202 Interest of your spouse
Qin Hongchao 2501 Other
Qin Yan 2201 Interest of corporation controlled by you
Sun Mingyan 2202 Interest of your spouse

Honliv Healthcare Management Group Co Headlines

No Headlines